(5Z)-5-[(5-Bromo-2-ethoxyphenyl)methylidene]-3-[(pyridin-3-yl)methyl]-2-sulfanylideneimidazolidin-4-one

Catalog No. :
ACRQFD640
CAS No. :
320422-91-1
Molecular Formula :
C18H16BrN3O2S
Molecular Weight :
418.32

IUPAC Name:(Z)-5-(5-bromo-2-ethoxybenzylidene)-3-(pyridin-3-ylmethyl)-2-thioxoimidazolidin-4-one

(5Z)-5-[(5-Bromo-2-ethoxyphenyl)methylidene]-3-[(pyridin-3-yl)methyl]-2-sulfanylideneimidazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5Z)-5-[(5-Bromo-2-ethoxyphenyl)methylidene]-3-[(pyridin-3-yl)methyl]-2-sulfanylideneimidazolidin-4-one
IUPAC Name(Z)-5-(5-bromo-2-ethoxybenzylidene)-3-(pyridin-3-ylmethyl)-2-thioxoimidazolidin-4-one
Molecular FormulaC18H16BrN3O2S
Molecular Weight418.32
SMILESO=C(/C(N1)=C/C2=CC(Br)=CC=C2OCC)N(CC3=CC=CN=C3)C1=S
InChI KeyKNBVOPQEYQBQBA-DHDCSXOGSA-N
Synonym5-[(5-BROMO-2-ETHOXYPHENYL)METHYLENE]-3-(3-PYRIDINYLMETHYL)-2-THIOXOTETRAHYDRO-4H-IMIDAZOL-4-ONE;(5Z)-5-[(5-bromo-2-ethoxyphenyl)methylidene]-3-[(pyridin-3-yl)methyl]-2-sulfanylideneimidazolidin-4-one;4-Imidazolidinone, 5-[(5-bromo-2-ethoxyphenyl)methylene]-3-(3-pyridinylmethyl)-2-thioxo-
CAS No.320422-91-1

Synthetic Route by SureRoute

1. ACRQFD640 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLFUZ971 route compound structure diagram
    ACLFUZ97179636-94-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRQFD640 route product structure diagram
    ACRQFD640320422-91-1
Inquiry

2. ACRQFD640 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRQFD640 route product structure diagram
    ACRQFD640320422-91-1
Inquiry

Comments (0)